Jan 23, 2019
Worldwide, depression will be the single biggest cause of disability in the next 20 years. But treatment for it has not changed much in the last three decades. In the world of psychiatry, time has apparently stood still… until now.
In this game-changing book, University of Cambridge Professor Edward Bullmore reveals the breakthrough new science on the link between depression and inflammation of the body and brain. He explains how and why we now know that mental disorders can have their root cause in the immune system, and outlines a future revolution in which treatments could be specifically targeted to break the vicious cycle of stress, inflammation and depression.
The Inflamed Mind goes far beyond the clinic and the lab, representing a whole new way of looking at how mind, brain and body all work together in a sometimes misguided effort to help us survive in a hostile world. It offers insights into the story of Western medicine, how we have got it wrong as well as right in the past, and how we could start getting to grips with depression and other mental disorders much more effectively in the future.
““This is an important book, a hopeful book, for anyone who wants to think about depression in a new way.” ”
““The Inflamed Mind is not only a dramatic breakthrough in our understanding of depression. It is an extraordinary exploration of what it is to be human.””
“"Suddenly an expert who wants to stop and question everything we thought we knew... This is a lesson in the workings of the brain far too important to ignore."”
Professor Edward Bullmore MB PhD FRCP FRCPsych FMedSci trained in medicine at the University of Oxford and then at St Bartholomew’s Hospital in London. After working as a physician in London and in the University of Hong Kong, he trained as a psychiatrist at St George’s Hospital and the Bethlem Royal and Maudsley Hospitals in London, and as a clinical scientist at the Institute of Psychiatry, King’s College London. He has been a Professor of Psychiatry at the University of Cambridge since 1999 and is currently Head of the Department of Psychiatry and Director of the Wolfson Brain Imaging Centre in the Department of Clinical Neurosciences. Since 2005, he has also worked half-time for GlaxoSmithKline and is currently leading an academic-industrial partnership for the development of new anti-inflammatory drugs for depression. He is a world expert in neuroscience and mental health.